134 related articles for article (PubMed ID: 7480556)
1. Differential effects of flumazenil in alcoholic and nonalcoholic cirrhotic patients.
Kapczinski F; Sherman D; Williams R; Lader M; Curran V
Psychopharmacology (Berl); 1995 Jul; 120(2):220-6. PubMed ID: 7480556
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairments of alcoholic cirrhotic patients: correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors.
Kapczinski F; Curran HV; Przemioslo R; Williams R; Fluck E; Fernandes C; File SE
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):676-80. PubMed ID: 8648337
[TBL] [Abstract][Full Text] [Related]
3. The influence of alcoholism and cirrhosis on benzodiazepine receptor function.
Fluck E; Fernandes C; File SE; Curran HV; Marshall J
Pharmacol Biochem Behav; 1998 Apr; 59(4):949-54. PubMed ID: 9586854
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients.
Edwin D; Flynn L; Klein A; Thuluvath PJ
Hepatology; 1999 Dec; 30(6):1363-7. PubMed ID: 10573512
[TBL] [Abstract][Full Text] [Related]
5. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
[TBL] [Abstract][Full Text] [Related]
6. Flumazenil and hepatic encephalopathy.
Amaral OB; Quevedo J; Walz R; Kapczinski F
Hepatology; 1999 Apr; 29(4):1338-9. PubMed ID: 10336339
[No Abstract] [Full Text] [Related]
7. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
[TBL] [Abstract][Full Text] [Related]
8. Visual event-related potentials in cirrhotic patients without overt encephalopathy: the effects of flumazenil.
Jones EA; Giger-Mateeva VI; Reits D; Riemslag FC; Liberov B; Spekrijse H
Metab Brain Dis; 2001 Jun; 16(1-2):43-53. PubMed ID: 11726088
[TBL] [Abstract][Full Text] [Related]
9. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
Van der Rijt CC; Schalm SW; Meulstee J; Stijnen T
Gastroenterol Clin Biol; 1995; 19(6-7):572-80. PubMed ID: 7590022
[TBL] [Abstract][Full Text] [Related]
10. Brain morphologic characteristics of cirrhotic alcoholics and cirrhotic nonalcoholics: an MRI study.
Barthauer L; Tarter R; Hirsch W; Van Thiel D
Alcohol Clin Exp Res; 1992 Oct; 16(5):982-5. PubMed ID: 1443439
[TBL] [Abstract][Full Text] [Related]
11. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
[TBL] [Abstract][Full Text] [Related]
12. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
Ozyilkan E; Kahraman H; Onar M; Kesim G; Arik Z
East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
[TBL] [Abstract][Full Text] [Related]
13. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of acute hepatic encephalopathy with flumazenil].
Viel E; de La Coussaye JE; Bassoul B; Saissi G; Eledjam JJ
Ann Fr Anesth Reanim; 1990; 9(4):386-9. PubMed ID: 2119157
[TBL] [Abstract][Full Text] [Related]
15. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study.
Amodio P; Marchetti P; Del Piccolo F; Beghi A; Comacchio F; Carraro P; Campo G; Baruzzo L; Marchiori C; Gatta A
Clin Physiol; 1997 Sep; 17(5):533-9. PubMed ID: 9347201
[TBL] [Abstract][Full Text] [Related]
16. A randomised crossover trial of post-operative cognitive and psychomotor recovery from benzodiazepine sedation: effects of reversal with flumazenil over a prolonged recovery period.
Girdler NM; Fairbrother KJ; Lyne JP; Neave N; Scholey A; Hargaden N; Wesnes KA; Engler J; Rotherham NA
Br Dent J; 2002 Mar; 192(6):335-9; discussion 331. PubMed ID: 15552071
[TBL] [Abstract][Full Text] [Related]
17. Isokinetic muscle strength and its association with neuropsychological capacity in cirrhotic alcoholics.
Tarter RE; Panzak G; Switala J; Lu S; Simkevitz H; Van Thiel D
Alcohol Clin Exp Res; 1997 Apr; 21(2):191-6. PubMed ID: 9113251
[TBL] [Abstract][Full Text] [Related]
18. The interactions of midazolam and flumazenil on human memory and cognition.
Ghoneim MM; Block RI; Ping ST; el-Zahaby HM; Hinrichs JV
Anesthesiology; 1993 Dec; 79(6):1183-92. PubMed ID: 8267193
[TBL] [Abstract][Full Text] [Related]
19. Effect of flumazenil on recovery after midazolam and propofol sedation.
Ghouri AF; Ruiz MA; White PF
Anesthesiology; 1994 Aug; 81(2):333-9. PubMed ID: 8053582
[TBL] [Abstract][Full Text] [Related]
20. Abstracting capacity in cirrhotic alcoholics: negative findings.
Tarter RE; Switala J; Lu S; Van Thiel D
J Stud Alcohol; 1995 Jan; 56(1):99-103. PubMed ID: 7752641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
